Guozhen Tan

616 total citations
30 papers, 468 citations indexed

About

Guozhen Tan is a scholar working on Immunology, Rheumatology and Dermatology. According to data from OpenAlex, Guozhen Tan has authored 30 papers receiving a total of 468 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Immunology, 12 papers in Rheumatology and 5 papers in Dermatology. Recurrent topics in Guozhen Tan's work include Systemic Lupus Erythematosus Research (9 papers), Psoriasis: Treatment and Pathogenesis (7 papers) and Galectins and Cancer Biology (6 papers). Guozhen Tan is often cited by papers focused on Systemic Lupus Erythematosus Research (9 papers), Psoriasis: Treatment and Pathogenesis (7 papers) and Galectins and Cancer Biology (6 papers). Guozhen Tan collaborates with scholars based in China, United States and Russia. Guozhen Tan's co-authors include Fanqin Zeng, Qing Guo, Hui Xiong, Zengqi Tang, Zhenrui Shi, Xiuting Liu, Ying Xu, Hongfeng Tang, Liang‐Chun Wang and Qing Guo and has published in prestigious journals such as PLoS ONE, Frontiers in Immunology and Cell Cycle.

In The Last Decade

Guozhen Tan

27 papers receiving 462 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Guozhen Tan China 13 256 158 102 71 52 30 468
Makoto Shiozaki Japan 12 53 0.2× 152 1.0× 40 0.4× 66 0.9× 52 1.0× 22 401
Bing‐Xi Yan China 10 164 0.6× 156 1.0× 23 0.2× 67 0.9× 48 0.9× 19 417
Julia Holstein Germany 10 124 0.5× 132 0.8× 102 1.0× 133 1.9× 94 1.8× 14 516
Jiejie Geng China 12 136 0.5× 310 2.0× 43 0.4× 14 0.2× 64 1.2× 13 543
Ali Memarian Iran 16 370 1.4× 198 1.3× 90 0.9× 10 0.1× 140 2.7× 37 648
Susanna Choi South Korea 9 151 0.6× 132 0.8× 71 0.7× 8 0.1× 58 1.1× 16 370
Daniela Di Marcantonio United States 15 49 0.2× 417 2.6× 23 0.2× 10 0.1× 148 2.8× 29 569
Andrew C. Little United States 10 167 0.7× 309 2.0× 17 0.2× 10 0.1× 75 1.4× 13 499
Monika Doll Germany 12 70 0.3× 215 1.4× 11 0.1× 16 0.2× 68 1.3× 19 326
Jian‐Ching Wu Taiwan 12 56 0.2× 260 1.6× 63 0.6× 5 0.1× 74 1.4× 18 472

Countries citing papers authored by Guozhen Tan

Since Specialization
Citations

This map shows the geographic impact of Guozhen Tan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guozhen Tan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guozhen Tan more than expected).

Fields of papers citing papers by Guozhen Tan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guozhen Tan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guozhen Tan. The network helps show where Guozhen Tan may publish in the future.

Co-authorship network of co-authors of Guozhen Tan

This figure shows the co-authorship network connecting the top 25 collaborators of Guozhen Tan. A scholar is included among the top collaborators of Guozhen Tan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guozhen Tan. Guozhen Tan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tan, Guozhen, Fei Liu, Xin Huang, et al.. (2025). A multi-step joint noise reduction method of the distributed acoustic sensor data for flow rate monitoring. Measurement. 256. 118151–118151.
2.
Wu, Xuesong, Xiuting Liu, Yanyun Jiang, et al.. (2024). Topical treatment of tyrosine kinase 2 inhibitor through borneol-embedded hydrogel: Evaluation for preventive, therapeutic, and Recurrent management of psoriasis. Bioactive Materials. 41. 83–95. 8 indexed citations
3.
Liu, Xiuting, et al.. (2024). Decreased HMGCS1 inhibits proliferation and inflammatory response of keratinocytes and ameliorates imiquimod-induced psoriasis via the STAT3/IL-23 axis. International Immunopharmacology. 133. 112033–112033. 9 indexed citations
4.
Qiu, Xiaonan, Zhenrui Shi, Si‐Yao Lu, et al.. (2023). TNF-α promotes CXCL-1/8 production in keratinocytes by downregulating galectin-3 through NF-κB and hsa-miR-27a-3p pathway to contribute psoriasis development. Immunopharmacology and Immunotoxicology. 45(6). 692–700. 5 indexed citations
5.
Xiong, Hui, Ni Kong, Jiongjie Jing, et al.. (2023). Cytotoxic CD161−CD8+ TEMRA cells contribute to the pathogenesis of systemic lupus erythematosus. EBioMedicine. 90. 104507–104507. 15 indexed citations
6.
Liu, Xiuting, Zhenrui Shi, Si‐Yao Lu, et al.. (2022). Enhanced Migratory Ability of Neutrophils Toward Epidermis Contributes to the Development of Psoriasis via Crosstalk With Keratinocytes by Releasing IL-17A. Frontiers in Immunology. 13. 817040–817040. 17 indexed citations
7.
Shi, Zhenrui, Yuping Zhang, Xiaonan Qiu, et al.. (2022). Anti-galectin-3 antibodies induce skin vascular inflammation via promoting local production of IL-1β in systemic lupus erythematosus. International Immunopharmacology. 112. 109197–109197. 4 indexed citations
8.
Xiong, Hui, Zengqi Tang, Ying Xu, et al.. (2022). CD19+CD24highCD27+ B cell and interleukin 35 as potential biomarkers of disease activity in systemic lupus erythematosus patients. Advances in Rheumatology. 62(1). 48–48. 14 indexed citations
9.
Tian, Cuicui, Jianchi Ma, Xiuting Liu, et al.. (2022). Etanercept treatment of Stevens-Johnson syndrome and toxic epidermal necrolysis. Annals of Allergy Asthma & Immunology. 129(3). 360–365.e1. 14 indexed citations
10.
Qiu, Xiaonan, Lin Zheng, Xiuting Liu, et al.. (2021). ULK1 Inhibition as a Targeted Therapeutic Strategy for Psoriasis by Regulating Keratinocytes and Their Crosstalk With Neutrophils. Frontiers in Immunology. 12. 714274–714274. 19 indexed citations
11.
Shi, Zhenrui, Jing Yin, Yuping Zhang, et al.. (2020). The diagnostic benefit of antibodies against ribosomal proteins in systemic lupus erythematosus. Advances in Rheumatology. 60(1). 45–45. 6 indexed citations
12.
Guo, Qing, et al.. (2018). Acute renal injury induced by oral valacyclovir. European Journal of Dermatology. 28(1). 122–123.
13.
Xiong, Hui, Ying Xu, Guozhen Tan, et al.. (2015). Glycyrrhizin Ameliorates Imiquimod-Induced Psoriasis-like Skin Lesions in BALB/c Mice and Inhibits TNF-a-Induced ICAM-1 Expression via NF-κB/MAPK in HaCaT Cells. Cellular Physiology and Biochemistry. 35(4). 1335–1346. 78 indexed citations
14.
Zeng, Fanqin, Xiaowen Huang, Qun Li, et al.. (2014). Successful Treatment of a Necrotizing Fasciitis Patient Caused by Mucor indicus with Amphotericin B and Skin Grafting. Mycopathologia. 177(3-4). 187–192. 6 indexed citations
16.
Zeng, Fanqin, Guozhen Tan, Chuntao Yang, et al.. (2013). Hydrogen Sulfide Inhibits Abnormal Proliferation of Lymphocytes via AKT/GSK3� Signal Pathway in Systemic Lupus Erythematosus Patients. Cellular Physiology and Biochemistry. 31(6). 795–804. 44 indexed citations
17.
Guo, Qing, et al.. (2012). Mesenchymal Stem Cell Transplantation Inhibits Abnormal Activation of Akt/GSK3� Signaling Pathway in T Cells from Systemic Lupus Erythematosus Mice. Cellular Physiology and Biochemistry. 29(5-6). 705–712. 32 indexed citations
18.
Guo, Qing, et al.. (2012). Psoriasis Is Associated with Low Serum Levels of Hydrogen Sulfide, a Potential Anti-inflammatory Molecule. The Tohoku Journal of Experimental Medicine. 228(4). 325–332. 30 indexed citations
19.
Zeng, Kang, et al.. (2011). Allogeneic adipose-derived stem cells suppress Th17 lymphocytes in patients with active lupus <italic>in vitro</italic>. Acta Biochimica et Biophysica Sinica. 43(10). 805–812. 20 indexed citations
20.
Tang, Hongfeng, Guozhen Tan, Qing Guo, Rui‐Ping Pang, & Fanqin Zeng. (2009). Abnormal activation of the Akt-GSK3β signaling pathway in peripheral blood T cells from patients with systemic lupus erythematosus. Cell Cycle. 8(17). 2789–2793. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026